Neuroblastoma chemotherapy can be augmented by immunotargeting O-acetyl-GD2 tumor-associated ganglioside - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles OncoImmunology Year : 2018

Neuroblastoma chemotherapy can be augmented by immunotargeting O-acetyl-GD2 tumor-associated ganglioside

Domains

Cancer

Elizabeth Bernardo  : Connect in order to contact the contributor

https://www.hal.inserm.fr/inserm-01596068

Submitted on : Wednesday, September 27, 2017-10:59:08 AM

Last modification on : Wednesday, May 24, 2023-4:13:03 PM

Consult the full text

Dates and versions

inserm-01596068 , version 1 (27-09-2017)

Identifiers

Cite

S. Faraj, M. Bahri, S. Fougeray, A. El Roz, J. Fleurence, et al.. Neuroblastoma chemotherapy can be augmented by immunotargeting O-acetyl-GD2 tumor-associated ganglioside. OncoImmunology, 2018, 7 (1), ⟨10.1080/2162402X.2017.1373232⟩. ⟨inserm-01596068⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

INSERM UNIV-NANTES CNRS UNIV-ANGERS UNAM CRCINA RMES NANTES-UNIVERSITE ONIRIS UFR-MEDECINE-NANTES
124 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More